본문 바로가기

Data Plus(+)

All 807,818 Page 19,805/80,782

검색

Contents

No Journal_name Subject Date DOI Author
609778 ONCOTARGETS AND THERAPY

Simultaneous Inhibition of Ornithine Decarboxylase 1 and Pyruvate Kinase M2 Exerts Synergistic Effects Against Hepatocellular Carcinoma Cells

2020-11-01 10.2147/ott.s240535 Zeng Zhirui, Lan Jinzhi, Lei Shan, Yang Yushi, He Zhiwei, Xue Yan, Chen Tengxiang
609777 CANCER MANAGEMENT AND RESEARCH

YAP Triggers Bladder Cancer Proliferation by Affecting the MAPK Pathway

2020-11-01 10.2147/cmar.s273442 Qiu Dandan, Zhu Yan, Cong Zhicheng
609776 NEURO-ONCOLOGY NCOG-66. IMPLICATION OF D-DIMER IN THE DETECTION OF DEEP VENOUS THROMBOSIS (DVT) /PULMONARY EMBOLISM (PE) IN HIGH GRADE GLIOMA PATIENTS WITHOUT CLASSIC SYMPTOMS OF DVT/PE ON OR OFF AVASTIN TREATMENT | NCOG-66. IMPLICATION OF D-DIMER IN THE DETECTION OF DE 2020-11-01 10.1093/neuonc/noaa215.604 Jha Ruchika, Ranjan Tulika, Yu Alexander, Wegner Rodney, Karlovits Stephen
609775 NEURO-ONCOLOGY TAMI-07. THE IMMUNE MICROENVIRONMENT IN LOWER GRADE GLIOMAS | TAMI-07. THE IMMUNE MICROENVIRONMENT IN LOWER GRADE GLIOMAS 2020-11-01 10.1093/neuonc/noaa215.896 Kumar Anupam, Chen Katharine, Petritsch Claudia, Nicolaides Theodore, Santi-Vicini Mariarita, Perry Arie, Bollen Andrew, Solomon David, Molinaro Annette M, Phillips Joanna
609774 NEURO-ONCOLOGY NCMP-27. THE USE OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) DURING SEVERE NEUROTOXICITY AMONG THE RECIPIENTS OF CHIMERIC ANTIGEN RECEPTOR T-CELLS (CAR-T) THERAPY | NCMP-27. THE USE OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) DURING SEVERE NEUROTOXICITY AMONG THE RECIP 2020-11-01 10.1093/neuonc/noaa215.538 Mokhtari Sepideh, Asquith Justin, Bachmeier Christina, Faramand Rawan, Kim Youngchul, Peguero Edwin, Sahebjam Solmaz, Jain Michael, Vogelbaum Michael, Davila Marco, Forsyth Peter, Locke Frederick, Aleksandr Lazaryan
609773 NEURO-ONCOLOGY BIOM-07. EXPRESSION OF ANDROGEN RECEPTOR AND PROGRAMMED DEATH-LIGAND 1 IN BREAST-TO-BRAIN-METASTASES. | BIOM-07. EXPRESSION OF ANDROGEN RECEPTOR AND PROGRAMMED DEATH-LIGAND 1 IN BREAST-TO-BRAIN-METASTASES. 2020-11-01 10.1093/neuonc/noaa215.007 Qazi Maleeha, Jerzak Katarzyna, Nofech-Mozes Sharon
609772 RADIOTHERAPY AND ONCOLOGY : JOURNAL OF THE EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY OC-0575: Type 4 validation of dysphagia NTCP model for selection of HNC patients to the RCT, DAHANCA35 2020-11-01 10.1016/s0167-8140(21)00597-1 Hansen C.R., Van den Bosch L., Van der Laan H.P., Friborg J., Jensen K., Samsøe E., Johnsen L., Zukauskaite R., Grau C., Maare C., Johansen J., Primdahl H., Bratland Å., Kristensen C.A., Andersen M., Eriksen J.G., Langendijk J.A., Overgaard J., Van der Schaaf A.
609771 COMPUTATIONAL MATERIALS SCIENCE A quantitative phase-field model of gas bubble evolution in UO2 2020-11-01 10.1016/j.commatsci.2020.109867 Xiao Zhihua, Wang Yafeng, Hu Shenyang, Li Yulan, Shi San-Qiang
609770 GYNECOLOGIC ONCOLOGY REPORTS Metastatic epithelial ovarian cancer to Meckel’s cave with leptomeningeal spread at time of diagnosis 2020-11-01 10.1016/j.gore.2020.100641 Matthew Kahn Ryan, Kamlesh Gandhi Shreena, Rebecca Mvula Mwamba, Li Xuan, Frey Melissa K.
609769 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION : APJCP Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations 2020-11-01 10.31557/apjcp.2020.21.11.3291 Argirion Ilona, Zarins Katie, Suwanrungruang Krittika, Pongnikorn Donsuk, Chitapanarux Imjai, Sriplung Hutcha, Vatanasapt Patravoot, Rozek Laura